There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Richard LeLacheur is Vice President of Taylor Technology (USA).

Articles

Liquid chromatography-mass spectrometry (LC-MS) is a highly sensitive and specific analytical chemistry technique that is very commonly used in pharmacokinetic studies of new chemical entities.

LC-MS today and tomorrow

Janie Dubois is Product Manager, Analytical Imaging, Malvern Instruments (USA).

The author assesses the power and limitations of NIR chemical imaging and its future.

When and why should the pharmaceutical industry use NIR chemical imaging?

Patrick Bennett is Strategic Marketing Director - Pharma for Thermo Fisher Scientific.

Bioanalysis has migrated from a very general vocation to one that requires more specialization, particularly in GLP applications.

Bioanalysis: hurdles and hopes

X-ray powder diffraction (XRPD) is a key analytical technique in the pharmaceutical industry, providing direct information about the crystalline and amorphous components in pharmaceutical formulations in a non-destructive manner and without laborious sample preparation.

New possibilities for X-ray analysis

NIR chemical imaging is based on the same principles as NIR spectroscopy, but uses a focal plane array detector in place of a single detector element to capture the spectral signature at tens of thousands of spatially resolved positions simultaneously.

When and why should the pharmaceutical industry use NIR

Tony Copley is Managing Director of Copley Scientific.

Having been directly involved in the evolution of dissolution testing since its introduction in the early 1970s and variously representing Hanson, Van Kel, Sotax and Erweka prior to developing our own range of dissolution testers in 2002, I would have to say that advances in dissolution testing technology have been one of the biggest breakthroughs in solid dosage form testing over the last decade.

Innovations in dissolution testing

Charles River Acquires WuXi AppTec; Amgen Appoints President and COO; and More.

Week Of April 26, 2010: Company And People Notes: Charles River Acquires WuXi AppTec; Amgen Appoints President and COO; and More.

FDA Issues Warning Letters to Astellas, GSK, And Novartis; Sandoz Acquires Oriel Therapeutics; And More.

Week Of April 19, 2010: Company And People Notes: FDA Issues Warning Letters to Astellas, GSK, And Novartis; Sandoz Acquires Oriel Therapeutics; And More.

Cephalon Completes Acquisition of Mepha; Xcellerex Appoints President and CEO; and More.

Week of April 12, 2010: Company and People Notes: Cephalon Completes Acquisition of Mepha; Xcellerex Appoints President and CEO; and More.

The US Pharmacopeial Convention welcomed Minghao Zhou of China's Zhejiang Provincial Institute for Food and Drug Control.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes